Welcome to our dedicated page for Halliburton SEC filings (Ticker: HAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Halliburton Company (HAL) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Halliburton, one of the world’s leading providers of products and services to the energy industry, uses these filings to report financial results, material agreements, leadership changes, and other significant events. This page organizes those documents and pairs them with AI-powered summaries to help readers understand their key points.
Investors can review current reports on Form 8-K, where Halliburton discloses items such as quarterly earnings releases, executive and board appointments, new executive agreements, and material credit facilities. For example, recent 8-K filings describe the appointment of senior leaders including an Executive Vice President and Chief Operating Officer, presidents for the Eastern and Western Hemispheres, a new chief accounting officer, and the addition of a board member. Other 8-Ks outline a multi-billion-dollar revolving credit agreement and the termination of a prior facility, as well as Halliburton’s minority interest in Voltagrid.
Filings related to results of operations and financial condition furnish earnings press releases that detail segment and regional performance, non-GAAP measures with reconciliations, and commentary on business conditions in Completion and Production and Drilling and Evaluation. These documents complement the company’s earnings calls and provide a structured view of Halliburton’s financial reporting.
Users interested in governance and compensation can find information on executive agreements and indemnification arrangements referenced in 8-K exhibits and proxy materials, which describe base salaries, participation in incentive plans, and indemnification terms for directors and executive officers. This page is updated as new filings are posted to EDGAR, while AI-generated highlights help readers quickly identify the sections most relevant to topics such as quarterly performance, capital structure, leadership changes, and significant contracts.
Halliburton Company reported director equity activity involving restricted stock units and common shares on December 5, 2025. A block of 6,092 shares of common stock was acquired at a price of $0 following the exercise of derivative securities, increasing the director's directly held common stock to 21,375 shares.
In the derivative table, 7,485 restricted stock units granted in December 2025 were acquired, each representing one share of common stock, with 7,485 derivative securities beneficially owned afterward. Another 6,092 restricted stock units from a December 5, 2024 grant were converted, leaving no units remaining from that grant. The restricted stock units vest in one year on the first anniversary of the award, with shares delivered upon vesting or, if elected, after the director ceases service.
Halliburton Company director reports new equity award in a Form 4 filing. On 12/05/2025, the director received 7,485 restricted stock units for Halliburton common stock. Each restricted stock unit represents the right to receive one share of common stock.
The 2025 restricted stock units vest in one year on the first anniversary of the award, with shares delivered upon vesting or, if the director elected deferral, after leaving the board. Following this award, the director holds 18,768.867 shares of Halliburton common stock directly, as well as derivative holdings that include 7,485 restricted stock units from 2025 and 6,226.77 restricted stock units from a 2024 award.
Halliburton Company director reported a new equity award consisting of 7,485 restricted stock units as of 12/05/2025. Each restricted stock unit represents the right to receive one share of Halliburton common stock and generally vests in one year on the first anniversary of the award, with delivery either at vesting or, if elected, after the director leaves the board.
The filing also lists previously granted restricted stock units tied to Halliburton common stock in amounts of 6,226.77, 5,040.19 and 4,028.23 shares, along with 11,728.754 stock equivalent units accrued under the company’s Directors’ Deferred Compensation Plan, which convert into common stock on a one-for-one basis following the director’s board service.
Halliburton Company reported a routine equity compensation update for one of its directors. On December 5, 2025, the director acquired 6,092 shares of common stock at $0, following the vesting of previously granted restricted stock units from a December 5, 2024 award. After this transaction, the director directly owned 87,496 shares of Halliburton common stock.
The director was also granted a new award of 7,485 restricted stock units dated December 2025, each representing the right to receive one share of common stock. These units vest in one year on the first anniversary of the award, with shares delivered upon vesting or, if the director elected deferral, after service as a director ends.
Halliburton Company director Form 4 filing reports an equity award. On 12/05/2025, the director received 7,485 restricted stock units, each representing the right to receive one share of Halliburton common stock.
The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered either when the units vest or, if the director has elected to defer receipt, after the director ceases serving on the board. The award is reported as a derivative security held directly by the director at an exercise price of $0.
Halliburton director reports restricted stock activity and share holdings. A Halliburton Co. director filed a Form 4 reporting equity compensation-related transactions on 12/05/2025. The director acquired 7,485 restricted stock units at an exercise price of $0, each representing one share of Halliburton common stock. On the same date, 6,092 restricted stock units granted on December 5, 2024 vested, resulting in the acquisition of 6,092 shares of common stock at $0.
Following these transactions, the director beneficially owns 580,688.509 shares of Halliburton common stock directly and 7,485 restricted stock units that each convert into one share. The filing notes that these restricted stock units vest in one year on the first anniversary of the award, with shares delivered upon vesting or, if elected, after the director leaves the board.
Halliburton Company reported an equity award to one of its directors on a Form 4. On 12/05/2025, the director acquired 7,485 restricted stock units (RSUs) tied to Halliburton common stock at an exercise price of $0, classified as an acquisition transaction. Each RSU represents a right to receive one share of common stock.
The RSUs from the 12/2025 grant vest in one year on the first anniversary of the award, with shares delivered either at vesting or, if the director elected deferral, after ceasing service as a director. The filing also shows previously granted RSUs from 12/2024 and 12/2023, with 6,226.77 and 5,040.19 underlying shares, respectively, including dividend equivalent units through September 30, 2025. Following the reported transactions, the RSUs are held in direct ownership.
Halliburton Company director reported equity awards and vesting activity dated 12/05/2025. The director acquired 7,485 restricted stock units (RSUs) labeled as "12/2025 Restricted Stock Units," each representing a right to receive one share of common stock. On the same date, 6,092 RSUs granted December 5, 2024 vested, resulting in the acquisition of 6,092 shares of common stock at a stated price of $0.
After these transactions, the director beneficially owned 16,643 shares of common stock directly. Additional RSU positions remain outstanding from prior annual grants, including blocks labeled as "12/2022" and "12/2021 Restricted Stock Units" that incorporate dividend equivalent units through September 30, 2025. The RSUs generally vest in one year on the first anniversary of the award, with shares delivered upon vesting or after service as a director if deferral was elected.
Halliburton Company director Form 4 details equity changes. On 12/05/2025, the director reported a disposition of 16,000 shares of Halliburton common stock. The filing also shows a new grant of 12/2025 restricted stock units covering 7,485 shares of common stock, reported as derivative securities.
Each restricted stock unit represents a right to receive one share of Halliburton common stock. The 12/2025 units vest in one year on the first anniversary of the award, with shares delivered upon vesting or, if the director elected to defer, after ceasing board service. The director also lists multiple outstanding restricted stock unit awards from 2016 through 2024, including dividend equivalent units through September 30, 2025.
Halliburton Company reported a new equity award for one of its directors. On December 5, 2025, the director acquired 7,485 restricted stock units (RSUs) tied to Halliburton common stock at a stated price of $0 per unit. Each RSU represents the right to receive one share of Halliburton common stock.
The 12/2025 RSUs vest in one year on the first anniversary of the award, with shares delivered either at vesting or, if the director elected deferral, after they cease serving as a director. The filing also lists multiple prior RSU grants and 19,310.229 stock equivalent units that convert into common stock on a one-for-one basis and are settled in shares following cessation as a director.
FAQ
What is the current stock price of Halliburton (HAL)?
What is the market cap of Halliburton (HAL)?
